Ameriprise
AURA icon

Ameriprise’s Aura Biosciences AURA Stock Holding History

Ameriprise’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
42,682
+413
+1% +$2.96K ﹤0.01% 3837
2026
Q1 		$283K Sell
42,269
-573
-1% -$3.29K ﹤0.01% 3773
2025
Q4 		$233K Sell
42,842
-77,898
-65% -$463K ﹤0.01% 3882
2025
Q3 		$746K Buy
120,740
+36,182
+43% +$237K ﹤0.01% 3481
2025
Q2 		$529K Buy
84,558
+20,065
+31% +$117K ﹤0.01% 3510
2025
Q1 		$378K Sell
64,493
-21,093
-25% -$160K ﹤0.01% 3596
2024
Q4 		$704K Sell
85,586
-2,006
-2% -$18.9K ﹤0.01% 3399
2024
Q3 		$780K Buy
+87,592
New +$751K ﹤0.01% 3316

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Ameriprise's AURA Position: Q2 2026 in Review

Ameriprise increased its Aura Biosciences (AURA) stake by 0.98% in Q2 2026, buying an estimated $2.96K and bringing the position to 42,682 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

Ameriprise first reported a position in AURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $780K in Q3 2024. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Ameriprise held 42,682 shares of Aura Biosciences worth $303K as of Q2 2026.
  • Ameriprise bought 413 Aura Biosciences shares in Q2 2026, an estimated $2.96K.
  • Aura Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3837 holding.
  • Ameriprise first reported a position in Aura Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Ameriprise's Aura Biosciences position peaked at $780K in Q3 2024.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.